This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Mitoxantrone injection USP (2014-11-21)
- Starting date:
- December 2, 2014
- Posting date:
- December 2, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-42789
Recalled products
Mitoxantrone injection USP
Reason
Lot A024636AC did not meet the specification for the individual unknown impurity during the stability testing.
Depth of distribution
Retailers
Affected products
Mitoxantrone injection USP
DIN, NPN, DIN-HIM
DIN 02244614
Dosage form
Solution
Strength
2 mg/mL
Lot or serial number
A024636AC
Companies
- Recalling Firm
-
Hospira Healthcare Corporation
Suite 600 - 1111 Dr. Frederik Philips Blvd
Saint-Laurent
H4M 1X6
Quebec
CANADA
- Marketing Authorization Holder
-
Hospira Healthcare Corporation
Suite 600 - 1111 Dr. Frederik Philips Blvd
Saint-Laurent
H4M 1X6
Quebec
CANADA